BAYLOR HEART AND VASCULAR HOSPITAL — History
CCN 450851 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$255M
Latest Revenue (FY2022)
+7.7%
Revenue CAGR (3yr)
30.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $220M | $242M | $255M | +5.4% | +7.7% |
| Operating Expenses | $149M | $163M | $178M | +9.4% | +9.2% |
| Operating Margin | 32.1% | 32.5% | 30.0% | -7.7% | -3.2% |
| Net Income | $71M | $79M | $77M | -2.7% | +4.2% |
| Licensed Beds | 53 | 53 | 53 | +0.0% | +0.0% |
| Total Patient Days | 9,524 | 9,781 | 9,928 | +1.5% | +2.1% |
| Medicare Day % | 38% | 37% | 34% | -6.7% | -5.3% |
| Medicaid Day % | 1% | 0% | 0% | +4136.3% | -21.5% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.9% ($220M → $255M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.7%
This Hospital
+7.6%
State Avg
Latest Margin
30.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $273M | 29.0% |
| FY2024 (proj) | $290M | 28.0% |
| FY2025 (proj) | $308M | 27.0% |